Incidence of diabetes mellitus among people living with and without HIV in British Columbia, Canada between 2001 and 2013: a longitudinal population-based cohort study.
HIV & AIDS
diabetes & endocrinology
epidemiology
Journal
BMJ open
ISSN: 2044-6055
Titre abrégé: BMJ Open
Pays: England
ID NLM: 101552874
Informations de publication
Date de publication:
11 05 2021
11 05 2021
Historique:
entrez:
13
5
2021
pubmed:
14
5
2021
medline:
5
6
2021
Statut:
epublish
Résumé
People living with HIV (PLHIV) are increasingly at risk of age-related comorbidities such as diabetes mellitus (DM). While DM is associated with elevated mortality and morbidity, understanding of DM among PLHIV is limited. We assessed the incidence of DM among people living with and without HIV in British Columbia (BC), Canada, during 2001-2013. We used longitudinal data from a population-based cohort study linking clinical data and administrative health data. We included PLHIV who were antiretroviral therapy (ART) naïve at baseline, and 1:5 age-sex-matched persons without HIV. All participants had ≥5 years of historic data pre-baseline and ≥1 year(s) of follow-up. DM was identified using the BC Ministry of Health's definitions applied to hospitalisation, physician billing and drug dispensation datasets. Incident DM was identified using a 5-year run-in period. In addition to unadjusted incidence rates (IRs), we estimated adjusted incidence rate ratios (IRR) using Poisson regression and assessed annual trends in DM IRs per 1000 person years (PYs) between 2001 and 2013. A total of 129 PLHIV and 636 individuals without HIV developed DM over 17 529 PYs and 88,672 PYs, respectively. The unadjusted IRs of DM per 1000 PYs were 7.4 (95% CI 6.2 to 8.8) among PLHIV and 7.2 (95% CI 6.6 to 7.8) for individuals without HIV. After adjustment for confounding, HIV serostatus was not associated with DM incidence (adjusted IRR: 1.03, 95% CI 0.83 to 1.27). DM incidence did not increase over time among PLHIV (Kendall trend test: p=0.9369), but it increased among persons without HIV between 2001 and 2013 (p=0.0136). After adjustment, HIV serostatus was not associated with incidence of DM, between 2001 and 2013. Future studies should investigate the impact of ART on mitigating the potential risk of DM among PLHIV.
Identifiants
pubmed: 33980535
pii: bmjopen-2021-048744
doi: 10.1136/bmjopen-2021-048744
pmc: PMC8118079
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
e048744Subventions
Organisme : CIHR
ID : 130419
Pays : Canada
Organisme : CIHR
ID : 143342
Pays : Canada
Informations de copyright
© Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.
Déclaration de conflit d'intérêts
Competing interests: None declared.
Références
Clin Infect Dis. 2007 Jul 1;45(1):111-9
pubmed: 17554711
Eur J Epidemiol. 2012 Aug;27(8):657-65
pubmed: 22722952
J Acquir Immune Defic Syndr. 2007 May 1;45(1):66-71
pubmed: 17245229
BMC Infect Dis. 2017 Feb 27;17(1):174
pubmed: 28241797
AIDS. 2017 Jun 19;31(10):1471-1481
pubmed: 28574965
Curr Opin HIV AIDS. 2016 Sep;11(5):492-500
pubmed: 27254748
Lancet. 2014 Jul 19;384(9939):241-8
pubmed: 25042234
AIDS. 2009 Jun 19;23(10):1227-34
pubmed: 19444074
BMJ Open Diabetes Res Care. 2017 Nov 26;5(1):e000457
pubmed: 29225896
BMC Public Health. 2015 Mar 17;15:255
pubmed: 25849566
J Int AIDS Soc. 2015 Oct 07;18:20261
pubmed: 26449273
AIDS Patient Care STDS. 2013 Jan;27(1):5-16
pubmed: 23305257
N Engl J Med. 2015 Aug 27;373(9):795-807
pubmed: 26192873
Endocrine. 2014 Sep;47(1):29-48
pubmed: 24532079
Lancet. 2014 Jun 7;383(9933):1999-2007
pubmed: 24910231
Diabetol Metab Syndr. 2014 Apr 03;6(1):50
pubmed: 24694251
Antivir Ther. 2012;17(3):549-56
pubmed: 22293506
J Assoc Nurses AIDS Care. 2011 Jan-Feb;22(1):17-25
pubmed: 20471864
PLoS One. 2012;7(9):e44575
pubmed: 22984529
BMJ Open. 2018 Jan 13;8(1):e019115
pubmed: 29331972
Int J Infect Dis. 2016 Dec;53:61-68
pubmed: 27756678
AIDS. 2007 Aug 20;21(13):1739-45
pubmed: 17690572
Int J STD AIDS. 2008 Aug;19(8):519-23
pubmed: 18663036
Diabetes Care. 2008 Jun;31(6):1224-9
pubmed: 18268071
PLoS One. 2016 Dec 22;11(12):e0168687
pubmed: 28005937
Curr Diab Rep. 2013 Jun;13(3):419-27
pubmed: 23446780
Int J Epidemiol. 2009 Dec;38(6):1624-33
pubmed: 19820106
AIDS Rev. 2016 Oct-Dec;18(4):198-211
pubmed: 27438580
PLoS One. 2013 Dec 18;8(12):e81355
pubmed: 24367482
J Adv Res. 2017 Mar;8(2):149-159
pubmed: 28149650
Lancet. 1994 Oct 22;344(8930):1120-4
pubmed: 7934494
Clin Infect Dis. 2011 Dec;53(11):1120-6
pubmed: 21998278
Arch Intern Med. 2005 May 23;165(10):1179-84
pubmed: 15911733
Lancet Public Health. 2017 Jan;2(1):e35-e46
pubmed: 29249478
Am J Public Health. 2015 Mar;105(3):431-7
pubmed: 25602898
Int J Drug Policy. 2018 May;55:31-39
pubmed: 29482150
PLoS One. 2017 Sep 8;12(9):e0184583
pubmed: 28886173
Diabetes Res Clin Pract. 2010 Jan;87(1):4-14
pubmed: 19896746
AIDS. 2019 Mar 15;33(4):675-683
pubmed: 30585844
Diabet Med. 2014 Oct;31(10):1185-93
pubmed: 24673640
BMJ Open Diabetes Res Care. 2017 Jan 5;5(1):e000304
pubmed: 28191320
Clin Infect Dis. 2007 Dec 15;45(12):1593-601
pubmed: 18190322
J Acquir Immune Defic Syndr. 2009 Apr 15;50(5):499-505
pubmed: 19223782
AIDS. 2007 May 31;21(9):1175-83
pubmed: 17502728
AIDS. 2012 Jan 28;26(3):303-14
pubmed: 22089377
BMC Public Health. 2014 Feb 13;14:161
pubmed: 24524286
AIDS. 2017 Jan 28;31(3):427-436
pubmed: 27831953